bn:01840343n
Noun Concept
EL
No term available
EN
Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma, a type of T cell non-Hodgkin lymphoma. Wikipedia
Relations
Sources